Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • terry_insm terry_insm Aug 7, 2013 8:52 AM Flag

    tycint - review period and possible launch

    The review period is aprx a year in Europe and is not included as preparation is an additional 6-9 months.
    Timelines are long in the drug approval process and investors should have facts, not skewing of info to pad
    your rah rah post
    Will Lewis hopefully optomistic mid 2015 launch of Arikace in Europe assumes no delays or problems such as shareholders experienced with rat data. Delays during the approval process happen often.

    As far as the US,,again your reality is "maybe" cross check reveals your /ID nonsense. get real clown....

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INSM
21.09+0.59(+2.88%)Mar 30 4:00 PMEDT